Antimicrobial peptides (AMPs) are part of the innate immune defense
mechanism of many organisms. Although AMPs have been essentially studied
and developed as potential alternatives for fighting infectious
diseases, their use as anticancer peptides (ACPs) in cancer therapy
either alone or in combination with other conventional drugs has been
regarded as a therapeutic strategy to explore.
This is the basis of an interesting article by Diana Gaspar, and colleagues at the Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal. The article has been published by Frontiers in Microbiology.
The reference is:
Gaspar D, Veiga AS and Castanho MARB (2013) From antimicrobial to anticancer peptides. A review. Front. Microbiol. 4:294. doi: 10.3389/fmicb.2013.00294
Posted by Tim Sandle
This is the basis of an interesting article by Diana Gaspar, and colleagues at the Instituto de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal. The article has been published by Frontiers in Microbiology.
The reference is:
Gaspar D, Veiga AS and Castanho MARB (2013) From antimicrobial to anticancer peptides. A review. Front. Microbiol. 4:294. doi: 10.3389/fmicb.2013.00294
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources